These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19352056)

  • 1. Regulatory mechanisms underlying corticotropin-releasing factor gene expression in the hypothalamus.
    Kageyama K; Suda T
    Endocr J; 2009; 56(3):335-44. PubMed ID: 19352056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells.
    Kageyama K; Hanada K; Iwasaki Y; Sakihara S; Nigawara T; Kasckow J; Suda T
    J Endocrinol; 2007 Nov; 195(2):199-211. PubMed ID: 17951532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction in the hypothalamic corticotropin-releasing factor system and its clinical implications.
    Kageyama K; Tamasawa N; Suda T
    Stress; 2011 Jul; 14(4):357-67. PubMed ID: 21438777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of regulatory elements on corticotropin-releasing factor gene promoter in hypothalamic 4B cells.
    Kageyama K; Hanada K; Takayasu S; Iwasaki Y; Sakihara S; Nigawara T; Suda T
    J Endocrinol Invest; 2008 Dec; 31(12):1079-85. PubMed ID: 19246974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotrophin-releasing factor gene transcription is directly activated after deprivation of glucocorticoids in hypothalamic cells.
    Kageyama K; Akimoto K; Suda T
    J Neuroendocrinol; 2010 Sep; 22(9):971-8. PubMed ID: 20626567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells.
    Kageyama K; Kumata Y; Akimoto K; Takayasu S; Tamasawa N; Suda T
    Stress; 2011 Sep; 14(5):520-9. PubMed ID: 21438782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and role of suppressor of cytokine signaling-3 in hypothalamic 4B cells.
    Kageyama K; Hanada K; Iwasaki Y; Suda T
    J Endocrinol; 2009 Jun; 201(3):369-76. PubMed ID: 19293294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of hypothalamic corticotropin-releasing factor gene.
    Kageyama K; Suda T
    Vitam Horm; 2010; 82():301-17. PubMed ID: 20472145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
    Scott LV; Dinan TG
    Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of glucagon-like peptide 1 and glucose levels on corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells.
    Kageyama K; Yamagata S; Akimoto K; Sugiyama A; Murasawa S; Suda T
    Mol Cell Endocrinol; 2012 Oct; 362(1-2):221-6. PubMed ID: 22801106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the expression of corticotropin-releasing factor gene by pyroglutamylated RFamide peptide in rat hypothalamic 4B cells.
    Ishigame N; Kageyama K; Takayasu S; Furumai K; Nakada Y; Daimon M
    Endocr J; 2016 Oct; 63(10):919-927. PubMed ID: 27452579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender difference in hypothalamic-pituitary-adrenal axis response to alcohol in the rat: activational role of gonadal steroids.
    Ogilvie KM; Rivier C
    Brain Res; 1997 Aug; 766(1-2):19-28. PubMed ID: 9359583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts.
    Lee S; Barbanel G; Rivier C
    Brain Res; 1995 Dec; 705(1-2):136-48. PubMed ID: 8821744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N; Kitamura K
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress.
    Hannibal J; Mikkelsen JD; Fahrenkrug J; Larsen PJ
    Endocrinology; 1995 Sep; 136(9):4116-24. PubMed ID: 7649120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
    Bousquet C; Chesnokova V; Kariagina A; Ferrand A; Melmed S
    Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of corticotropin releasing factor expression and limitation of stress response.
    Aguilera G; Kiss A; Liu Y; Kamitakahara A
    Stress; 2007 Jun; 10(2):153-61. PubMed ID: 17514584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.